Navigation Links
Bioscience Bridge, LLC Launches as a Technology Transfer Agency for University-Based Bioscience Research
Date:3/17/2010

BOISE, Idaho, March 17 /PRNewswire/ -- A new professional services company has been launched focused on accelerating the connections of university-based bioscience research with commercial development opportunities. Bioscience Bridge, LLC was formed by Michelle Travis, principal and managing director, along with Mark Stinson, chief strategic officer.

(Logo:  http://www.newscom.com/cgi-bin/prnh/20100317/CG72294LOGO)

Bioscience Bridge is also supported by a team of consultants with experience in product strategy, marketing, business development, life science, legal, licensing and commercialization.

According to Ms. Travis, "We know that some of the best bioscience research comes from universities. Bioscience Bridge helps tech transfer offices at these universities get the technology out into the marketplace. This may be in the form of a start-up company or licensing agreements."

She adds, "We have the industry experience to bring the right companies to the universities."

University offices of technology transfer (OTT) have contacted Bioscience Bridge when they have a technology that is "stuck" or are looking for a technology portfolio evaluation.

Bioscience Bridge has several proprietary processes to assist OTTs:

  • Evaluation – using B.E.A.M.S.® to analyze university's specific technology or entire portfolio
  • Strategy – facilitating a Strategic GPS® to guide early stage technologies
  • Promotion – getting the right message in the right medium to the right people
  • Negotiation – assisting with the contract terms process leading to commercial agreements

Bioscience Bridge works with universities and life science companies around the world. They will be attending the AUTM 2010 Annual Meeting in New Orleans March 18-21, BIO International 2010 in Chicago May 3-6, and the Licensing Executives Society Spring Meeting in Boston, May 19-21. More information about Bioscience Bridge services, capabilities, and connections is online at www.biosciencebridge.com

About Bioscience Bridge, LLC:

Bioscience Bridge, LLC is a global technology transfer agency. We accelerate the connections of university-based bioscience research with commercial development opportunities. We are unique because we support tech transfer offices with our bioscience industry experience and a proven process in the evaluation, strategy, promotion and negotiation of licensing, collaboration or start up arrangements. The agency is a member of Association of Technology Managers (AUTM) and the Licensing Executives Society (LES). More information is on the Bioscience Bridge website at www.biosciencebridge.com

SOURCE Bioscience Bridge, LLC

Back to top

RELATED LINKS
http://www.biosciencebridge.com

'/>"/>

SOURCE Bioscience Bridge, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Neurocrine Biosciences, Inc. Announces Exercise of Over-Allotment Option for Common Stock Offering
2. YM BioSciences announces AACR acceptance of two nimotuzumab poster presentations
3. Neurocrine Biosciences to Present at the Roth 22nd Annual OC Growth Conference
4. YM BioSciences closes US$17.5 million financing
5. YM BioSciences to raise approximately US$15 million
6. Sangamo BioSciences Announces Presentation at Cowen and Company Health Care Conference
7. TEI Biosciences PriMatrix(TM) Awarded Seal of Approval by American Podiatric Medical Association
8. KGI Study Reveals Diverse and Vibrant Regional Bioscience Industry
9. YM BioSciences presents CYT387 and CYT997 data at international cancer conference
10. YM BioSciences granted two US patents for AeroLEF(R)
11. Ardea Biosciences Announces Appointment of Felix J. Baker, Ph.D. to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... ... 17, 2017 , ... Pono Ola , a mind-body wellness firm on ... the official launch of its much-anticipated Pono Board: a re-invented fitness and anti-fatigue balance ... for over a year, the patented Pono Board is the world’s only exercise balance ...
(Date:1/17/2017)...  Protagonist Therapeutics, Inc. (NASDAQ: PTGX ... global Phase 2b induction study in ulcerative colitis ... integrin. The aim of this randomized, double-blind, placebo-controlled, ... and efficacy of PTG-100 in approximately 240 adult ... disease. "We are very pleased ...
(Date:1/16/2017)... ... January 16, 2017 , ... ... Tibbetts Award from the U.S. Small Business Administration. The Tibbetts Award ... economic or social impact […] and are considered the best of the best ...
(Date:1/13/2017)... Research and Markets has announced the addition ... Forecast to 2021" report to their offering. ... The biosimilars market is expected ... in 2016, at a CAGR of 26.3%. The ... type, and application. Factors such as rising incidence of various diseases, ...
Breaking Biology Technology:
(Date:12/16/2016)... , Dec 16, 2016 Research and Markets ... Market - Global Forecast to 2021" report to their offering. ... The biometric ... grow at a CAGR of 14.06% from 2016 to 2021. The ... is projected to reach 854.8 Million by 2021. The growth of ...
(Date:12/15/2016)... ... announced the addition of the "Global Military Biometrics Market 2016-2020" ... military biometrics market to grow at a CAGR of 7.5% during the ... an in-depth market analysis with inputs from industry experts. The report covers ... report also includes a discussion of the key vendors operating in this ...
(Date:12/12/2016)... , Dec. 12, 2016  Researchers at Trinity ... for graphene by combining the material with Silly ... sensitive pressure detector able to sense pulse, blood ... small spider.  The research team,s ... be read here:  http://science.sciencemag.org/content/354/6317/1257 ...
Breaking Biology News(10 mins):